Inactive Instrument

Other languages OXFORD BIOMEDICA Swiss Exchange

Equities

ArcticZymes Technologies Nominates New Chair	Jun. 25
EARNINGS AND TRADING: Cordel thrilled by Middle East contract win	Jun. 18
Avon Protection wins UK MoD supply deal; Molten Ventures up	May. 09
Molten Ventures wins UK MoD supply contract	May. 09
NatWest target raised, other lenders backed	May. 09
Jefferies cuts AJ Bell; Deutsche likes ConvaTec	May. 03
FTSE 100 as investors look to Fed rate decision	Apr. 29
Oxford BioMedica bullish; Petrofac slumps	Apr. 29
Earnings Flash (OXB.L) OXFORD BIOMEDICA Reports FY23 Revenue GBP89.5M	Apr. 29
Oxford Biomedica plc Reiterates Earnings Guidance for the Year 2024	Apr. 29
Oxford Biomedica plc Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 29
HSBC likes Haleon, cuts Flutter to 'hold'	Apr. 18
EARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stake	Mar. 20
Oxford Biomedica Secures New Deal, Expands Existing Agreements for Clinical Programs	Mar. 20
Oxford Biomedica plc Announces Board Changes	Mar. 11
EARNINGS AND TRADING: Harland & Wolff wins major Falklands contract	Mar. 05
Oxford Biomedica plc Provides Earnings Guidance for the Year Ended December 31, 2023 and for the Fiscal Year 2024	Mar. 05
Barclays cuts Bank of Ireland to 'equal weight'	Mar. 05
EnSilica hires new chief financial officer from Oxford Biomedica	Feb. 05
EnSilica Appoints Oxford Biomedica Executive as CFO	Feb. 05

No results for this search